HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$5.04
Day range
$5.03 - $5.13
Year range
$4.26 - $6.05
Market cap
39.14M USD
Avg Volume
7.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.10M | 30.30% |
Operating expense | 2.26M | -13.89% |
Net income | -1.14M | 31.66% |
Net profit margin | -22.37 | 47.55% |
Earnings per share | — | — |
EBITDA | 198.39K | 145.04% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 978.74K | -83.10% |
Total assets | 43.81M | -2.35% |
Total liabilities | 18.82M | 29.93% |
Total equity | 24.99M | — |
Shares outstanding | 7.75M | — |
Price to book | 1.57 | — |
Return on assets | -2.70% | — |
Return on capital | -2.82% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.14M | 31.66% |
Cash from operations | -723.07K | 44.29% |
Cash from investing | 33.78K | 102.27% |
Cash from financing | -321.43K | -29.50% |
Net change in cash | -1.01M | 66.71% |
Free cash flow | 68.16K | 103.74% |
About
Founded
1982
Headquarters
Website
Employees
77